A carcinoid tumor is a type of neuroendocrine tumor that can develop in hormone-producing cells. These tumors are often slow-growing, but some can grow faster or spread to other parts of the body. The treatment depends on where the tumor started, its size, grade, and whether it has spread. :contentReference[oaicite:0]{index=0}

Carcinoid tumors can occur in places such as the small intestine, appendix, rectum, stomach, and lungs. Some tumors may release hormones and cause symptoms such as flushing or diarrhea, while others may cause no clear symptoms in the early stages. :contentReference[oaicite:1]{index=1}

Treatment in India may include surgery, somatostatin analog therapy, targeted treatments, PRRT, radiation, or chemotherapy in selected cases. The right option depends on the individual tumor and the patient's overall health. :contentReference[oaicite:2]{index=2}

Patients can start with an online consultation by sharing their biopsy, pathology reports, scans, and previous treatment records. The medical team can review the case and explain suitable treatment options and the next steps.

What Is a Carcinoid Tumor?

A carcinoid tumor is a type of neuroendocrine tumor (NET). It starts in cells called neuroendocrine cells, which can make and release hormones or hormone-like substances. These tumors can grow slowly, but some can behave more aggressively and spread to other parts of the body.

What Are Neuroendocrine Cells?

Neuroendocrine cells are special cells found in many parts of the body. They receive signals from the nervous system and can release substances that help control different body functions. A tumor can develop when these cells begin to grow in an abnormal way.

Carcinoid Tumor and NET: What Is the Difference?

The word carcinoid has traditionally been used for certain well-differentiated neuroendocrine tumors, especially those that tend to grow slowly. Today, doctors often use the broader term neuroendocrine tumor (NET). The exact name and classification depend on the tumor's location and pathology findings.

Slow-Growing and More Aggressive Tumors

Many carcinoid tumors grow slowly and may remain limited to their original location for a long time. However, some neuroendocrine tumors can grow faster and spread to nearby lymph nodes or distant organs. The tumor's grade, differentiation, size, location, and spread help doctors understand how it may behave.

Where Can Carcinoid Tumors Develop?

Carcinoid tumors can develop in different organs. Common locations include the small intestine, appendix, rectum, stomach, and lungs. Less common neuroendocrine tumors can occur in other parts of the digestive system or body.

Types of Carcinoid Tumors

Carcinoid tumors are often described by where they start in the body. Their symptoms and treatment can be different depending on the location.

Small Intestine Carcinoid Tumor

These tumors commonly develop in the small intestine, particularly the ileum. Some may grow slowly for years before causing clear symptoms, while others can spread to nearby lymph nodes or the liver.

Appendix Carcinoid Tumor

Neuroendocrine tumors of the appendix are sometimes found unexpectedly after an appendix is removed. The need for additional treatment depends on factors such as tumor size, location, grade, and whether the tumor has spread.

Rectal Carcinoid Tumor

Rectal neuroendocrine tumors are often found during tests such as a colonoscopy. Small tumors may be treated locally in selected patients, while larger or more advanced tumors may need additional treatment.

Stomach Carcinoid Tumor

Stomach neuroendocrine tumors can develop from hormone-producing cells in the stomach. Different types can behave differently, so doctors consider the tumor type, size, number, grade, and underlying stomach condition.

Lung or Bronchial Carcinoid Tumor

Lung carcinoid tumors, also called bronchial carcinoids, develop in the airways. Some grow slowly, but they can sometimes cause symptoms such as persistent cough, wheezing, or repeated chest infections.

Other Rare Locations

Neuroendocrine tumors can occur in other organs and tissues as well. Because treatment depends strongly on the primary site, doctors first try to identify where the tumor started before planning treatment.

Carcinoid Tumor Symptoms

Symptoms depend on where the tumor is located, how large it is, and whether it produces hormones. Some carcinoid tumors cause no symptoms in the early stages and are found during tests performed for another reason.

Abdominal Pain

Tumors in the digestive system may cause abdominal pain, discomfort, bloating, or changes in bowel habits. Persistent or unexplained abdominal symptoms should be medically evaluated.

Diarrhea

Some neuroendocrine tumors release substances that can affect the digestive system and cause frequent or persistent diarrhea. Diarrhea can also have many other causes, so it does not by itself mean that a person has a carcinoid tumor.

Flushing

Some hormone-producing neuroendocrine tumors can cause sudden redness or warmth of the face and upper body. Repeated flushing may be part of carcinoid syndrome in patients whose tumors release certain hormones.

Wheezing or Breathing Problems

Lung or bronchial carcinoid tumors may cause coughing, wheezing, shortness of breath, or repeated respiratory problems. Similar symptoms can occur with many non-cancerous conditions and need proper evaluation.

Weight Changes

Unexplained weight loss can occur with some cancers, including advanced neuroendocrine tumors. Weight changes can also result from many other medical conditions, so they should be assessed in context.

Rectal Bleeding

Rectal bleeding can occur with tumors or other conditions affecting the rectum and digestive tract. Any unexplained or persistent rectal bleeding should be checked by a doctor.

Some Carcinoid Tumors Cause No Early Symptoms

A person can have a carcinoid tumor without obvious symptoms, particularly when the tumor is small. Some tumors are found during an endoscopy, colonoscopy, surgery, or imaging test performed for another reason.

Carcinoid Syndrome

Carcinoid syndrome is a group of symptoms that can happen when some neuroendocrine tumors release hormones and other substances into the bloodstream. It is more often seen when a tumor has spread to the liver, although it can occur in some other situations as well.

Flushing

The face, neck, or upper body may suddenly become red or feel warm. These episodes can come and go and may be triggered by certain foods, alcohol, stress, or other factors.

Diarrhea

Extra hormones released by some tumors can affect the digestive system and cause frequent or watery stools. Persistent diarrhea can also lead to dehydration and should be discussed with a doctor.

Wheezing or Breathing Problems

Some patients may develop wheezing or difficulty breathing because substances released by the tumor can affect the airways. Similar symptoms can have many other causes, so proper medical evaluation is important.

Fast Heartbeat

A rapid heartbeat can occur as part of carcinoid syndrome. If it happens repeatedly, especially along with flushing or diarrhea, the patient should inform the treating doctor.

Why Does Carcinoid Syndrome Happen?

Some neuroendocrine tumors produce substances such as serotonin and other vasoactive hormones. When these substances reach the bloodstream in higher amounts, they can cause symptoms such as flushing, diarrhea, wheezing, and a fast heartbeat.

Carcinoid Tumor Causes & Risk Factors

There is no single known cause for every carcinoid tumor. These tumors develop when neuroendocrine cells begin to grow abnormally. The risk can be influenced by the type of tumor, its location, family history, and certain inherited conditions.

Some neuroendocrine tumors are linked with inherited conditions such as multiple endocrine neoplasia type 1 (MEN1). However, most carcinoid tumors are not caused by an inherited condition.

Doctors consider the patient's age, medical history, family history, tumor location, and pathology findings when assessing possible risk factors.

Carcinoid Tumor Diagnosis

Diagnosis usually involves more than one test. Doctors first look at the patient's symptoms and medical history and then choose tests based on where the tumor is suspected to be located.

Blood and Urine Tests

Blood or urine tests may be used to look for hormones or other substances produced by neuroendocrine tumors. These tests can be particularly useful when symptoms suggest hormone release or carcinoid syndrome.

Endoscopy

An endoscopy or colonoscopy may be used to examine parts of the digestive system. If a suspicious area is found, a tissue sample may be collected for laboratory testing.

CT and MRI

CT and MRI scans can help doctors see the size and location of a tumor and check nearby lymph nodes or other areas of the body. The choice of scan depends on the suspected primary site.

PET Imaging

PET imaging may be used in selected patients to look for disease that may not be clear on routine scans. The type of PET scan depends on the tumor and the clinical question.

Biopsy

A biopsy removes a small amount of tissue from the suspected tumor. It may be performed during an endoscopic procedure, surgery, or another suitable procedure depending on the tumor's location.

Pathology

A pathologist examines the tissue under a microscope and may perform special tests to confirm that the tumor is a neuroendocrine tumor. The pathology report can also provide information about differentiation and grade.

Somatostatin Receptor Imaging

Some neuroendocrine tumors have somatostatin receptors on their surface. Special imaging, such as a somatostatin receptor PET scan, can help doctors find these tumors and assess whether treatments that target these receptors may be suitable.

Carcinoid Tumor Grade and Ki-67

Grade describes how quickly a neuroendocrine tumor is expected to grow. One important measurement used in pathology is the Ki-67 index, which estimates the percentage of tumor cells that are actively dividing.

Grade 1 (G1)

Grade 1 tumors generally have a low growth rate. They are usually well-differentiated and tend to grow more slowly than higher-grade tumors.

Grade 2 (G2)

Grade 2 tumors have an intermediate growth rate. They may behave more actively than Grade 1 tumors, so doctors consider the grade along with tumor location, size, and stage.

Grade 3 (G3)

Grade 3 tumors have a high proliferation rate. Some are well-differentiated NETs while others are poorly differentiated neuroendocrine carcinomas, so the pathology report needs to be interpreted carefully.

What Does Ki-67 Mean?

Ki-67 is a marker used by pathologists to estimate how many tumor cells are actively dividing. A higher Ki-67 generally indicates a faster-growing tumor. The exact cutoffs and classification can vary by tumor type and current pathology guidelines.

Why Does Grade Matter?

Grade helps doctors understand tumor behaviour and can influence treatment decisions. However, grade is only one part of the picture. The tumor's location, stage, differentiation, receptor status, symptoms, and overall health are also important.

Carcinoid Tumor Stages

Staging describes how far the tumor has grown or spread. Unlike some cancers, there is no single staging system that can be applied in exactly the same way to every carcinoid tumor. The TNM criteria depend on where the tumor started, such as the small intestine, appendix, rectum, stomach, or lung.

Carcinoid tumor staging depends on where the tumor started. The exact TNM criteria are different for different primary sites, so the stage should be determined from the pathology and imaging reports.

Doctors also consider whether the tumor can be completely removed, whether lymph nodes are involved, whether distant spread is present, and whether the disease has returned after earlier treatment. These factors can influence treatment even when two patients have the same broad stage.

Carcinoid Tumor Treatment in India

Treatment for a carcinoid tumor depends on its location, grade, stage, somatostatin receptor status, symptoms, whether it can be removed safely, and whether it has spread. There is no single treatment that is suitable for every patient.

Surgery

Surgery may be the main treatment when the tumor is localized and can be safely removed. The type of surgery depends on the organ involved and the size and location of the tumor.

Endoscopic Removal

Some small tumors in the digestive tract can be removed through an endoscopic procedure instead of open surgery. Whether this is appropriate depends on the tumor's size, depth, location, grade, and other pathology findings.

Somatostatin Analog Therapy

Medicines such as octreotide or lanreotide may be used for selected neuroendocrine tumors. They can help control hormone-related symptoms and may also slow tumor growth in appropriate patients.

PRRT

Peptide receptor radionuclide therapy (PRRT) may be considered for selected advanced neuroendocrine tumors that show suitable somatostatin receptor expression. The patient's scans, tumor characteristics, organ function, and previous treatment are reviewed before PRRT is considered.

Targeted Therapy

Targeted medicines may be used for selected advanced neuroendocrine tumors. The appropriate medicine depends on the tumor type, primary location, previous treatment, and other medical factors.

Radiation Therapy

Radiation may be used in selected situations, such as controlling a specific tumor area or helping manage symptoms caused by disease in certain locations. It is not required for every carcinoid tumor.

Chemotherapy

Chemotherapy is generally considered for selected neuroendocrine tumors, particularly when the disease is more aggressive or advanced and other treatments may not be suitable. The choice depends strongly on tumor grade and differentiation.

Liver-Directed Treatment

When a neuroendocrine tumor has spread to the liver, selected patients may benefit from liver-directed treatments. These can include procedures that target tumors within the liver, depending on the number, size, location, and extent of liver disease.

Symptom Control

Treatment may also focus on controlling symptoms caused by hormone release. Medicines such as somatostatin analogs can help reduce symptoms of carcinoid syndrome in appropriate patients. Additional supportive treatment may be needed for diarrhea, nutrition problems, breathing symptoms, or other treatment-related concerns.

Carcinoid Tumor Treatment by Stage

Treatment for a carcinoid tumor depends on how far the disease has spread, where the tumor started, its grade, and whether it can be removed safely. Doctors may use one treatment or a combination of treatments depending on the patient's condition.

Early or Localized Carcinoid Tumor

When the tumor is small and remains in its original location, surgery or endoscopic removal may be possible in selected patients. The exact approach depends on the tumor's size, depth, location, and pathology results.

Locally Advanced Carcinoid Tumor

A locally advanced tumor may have grown deeper into nearby tissues or structures. Treatment can involve surgery and, in selected cases, medicines or other treatments based on the tumor type and its location.

Lymph-Node-Positive Disease

If cancer cells are found in nearby lymph nodes, doctors assess the number and location of affected nodes along with the primary tumor. Surgery may be considered when appropriate, while additional treatment depends on the overall disease picture.

Metastatic Carcinoid Tumor

Metastatic disease means the tumor has spread to distant parts of the body. Treatment may focus on controlling tumor growth, reducing hormone-related symptoms, protecting organ function, and maintaining quality of life.

Recurrent Carcinoid Tumor

A recurrent tumor is one that returns after earlier treatment. Doctors may review new scans, pathology, previous treatments, and the current extent of disease before deciding whether surgery, medicines, PRRT, or another treatment is appropriate.

Surgery for Carcinoid Tumor

Surgery can be an important treatment when a carcinoid tumor is localized and can be removed safely. The type of operation depends on where the tumor started and how large or deep it is.

Local or Endoscopic Removal

Some small tumors in the digestive tract can be removed through an endoscopic procedure. This is considered only when the tumor has features that make local removal appropriate.

Surgical Removal of the Primary Tumor

Larger or deeper tumors may require an operation to remove the tumor and, when needed, nearby tissue. The extent of surgery depends on the organ involved and the risk of spread.

Lymph-Node Surgery

If nearby lymph nodes are involved or need to be assessed, lymph-node surgery may be performed along with removal of the primary tumor in selected patients.

Surgery for Metastatic Disease

Surgery is not suitable for every patient with metastatic disease. In selected cases, doctors may remove or reduce tumors in a particular organ, especially when this can help control the disease or its symptoms.

PRRT for Carcinoid Tumor

Peptide Receptor Radionuclide Therapy (PRRT) is a targeted treatment that may be used for selected neuroendocrine tumors. It uses a radioactive substance attached to a molecule that can bind to somatostatin receptors on suitable tumor cells.

When May PRRT Be Considered?

PRRT may be considered when a neuroendocrine tumor is advanced or metastatic and shows suitable somatostatin receptor expression on specialized imaging. Previous treatment, tumor behaviour, organ function, and overall health are also considered.

Somatostatin Receptor Positivity

A specialized somatostatin receptor scan can help doctors determine whether the tumor has enough of these receptors to make PRRT a possible treatment. A positive scan does not automatically mean that PRRT is suitable; the complete medical picture must be reviewed.

PRRT for Advanced or Metastatic Disease

PRRT is mainly considered for selected advanced neuroendocrine tumors that express somatostatin receptors. It may help control tumor growth and, in some patients, reduce symptoms caused by hormone-producing tumors.

Monitoring During PRRT

Patients receiving PRRT are monitored with blood tests and other assessments as advised by the treating team. Kidney function, blood counts, symptoms, and treatment response may be checked during the treatment course.

Carcinoid Tumor Treatment for Metastatic Disease

Metastatic carcinoid tumors can spread to different parts of the body. Treatment is selected according to where the disease has spread, how quickly it is growing, the tumor's grade and receptor status, symptoms, and previous treatment.

Liver Metastases

The liver is a common site for spread from some gastrointestinal neuroendocrine tumors. Depending on the number, size, and location of liver tumors, treatment may include surgery, liver-directed procedures, systemic medicines, or PRRT in suitable patients.

Lymph-Node Metastases

Nearby or distant lymph-node involvement is assessed using imaging and other tests. Surgery may be considered in selected situations, while medicines or other treatments may be used when the disease is more widespread.

Bone or Other Metastases

Neuroendocrine tumors can sometimes spread to bones or other organs. Treatment may include systemic therapy and, when appropriate, local treatment to help control a particular area and its symptoms.

Disease Control

For advanced disease, the aim may be to slow tumor growth, reduce the amount of cancer, control hormone-related symptoms, and maintain daily function. The treatment goal is different for every patient.

Symptom Control

Symptoms such as diarrhea, flushing, pain, weight loss, or breathing problems may need separate supportive treatment. Controlling these symptoms is an important part of care, especially when the disease is advanced.

Carcinoid Tumor Survival Rate

There is no single survival rate that applies to every person with a carcinoid tumor. Neuroendocrine tumors can behave very differently depending on where they start, how fast they grow, and whether they have spread.

Stage

A tumor that remains localized generally has a different outlook from one that has spread to distant organs. Stage helps doctors understand the extent of the disease.

Grade

Grade and the Ki-67 index provide information about how quickly tumor cells are dividing. Higher-grade disease may behave more aggressively than lower-grade disease.

Tumor Location

Survival and treatment outcomes can differ according to where the primary tumor started, such as the appendix, rectum, small intestine, stomach, or lung.

Tumor Size

Tumor size can be one of the factors doctors consider when assessing the disease. Its importance depends on the primary site and the applicable staging system.

Lymph-Node Involvement

Cancer cells in nearby lymph nodes can affect the stage and treatment plan. Doctors consider the number and location of involved nodes along with other disease features.

Metastasis

Spread to distant organs can change the treatment approach and overall prognosis. Even with metastatic disease, some neuroendocrine tumors can be controlled for long periods with appropriate treatment.

Treatment Response

How the tumor responds to treatment is another important factor. Doctors may use scans, blood tests, symptoms, and other disease-specific tests to assess response over time.

Is Carcinoid Tumor Curable?

Whether a carcinoid tumor can be cured depends on its location, size, grade, stage, and whether it has spread. Some localized tumors can be removed completely with curative intent, while advanced tumors may need long-term treatment to control the disease.

Localized Disease

When the tumor is limited to its original site and can be completely removed, surgery may offer a chance of long-term control or cure in selected patients. The final outlook depends on the pathology and other risk factors.

Role of Surgery

Surgery can be an important treatment for a localized carcinoid tumor. The type of surgery depends on the organ involved, tumor size, depth, grade, and whether nearby lymph nodes are affected.

Advanced Carcinoid Tumor

When a tumor has spread to distant organs, complete removal may not always be possible. Treatment may then focus on slowing tumor growth, controlling hormone-related symptoms, reducing tumor burden, and helping the patient maintain quality of life.

Remission and Disease Control

Remission means that tests show no detectable signs of disease or that the disease has significantly reduced. Disease control means the tumor is being kept stable or its growth is being slowed with treatment. These terms are not always the same as a permanent cure.

Can Carcinoid Tumor Come Back?

Yes. A carcinoid or neuroendocrine tumor can return after treatment in some patients. Regular follow-up helps doctors look for recurrence and decide whether additional treatment is needed.

Carcinoid Tumor Treatment Cost in India

The cost of carcinoid tumor treatment in India can vary widely. There is no single price because treatment depends on the tumor's location, grade, stage, treatment type, medicines, number of sessions, investigations, and overall patient needs.

Factors That Affect Treatment Cost

• Primary tumor location
• Stage and extent of disease
• Tumor grade and Ki-67
• Type of surgery required
• Number of treatment cycles
• PRRT or other advanced treatment requirements
• Medicines and supportive care
• Blood tests and imaging
• Hospital or day-care stay
• Whether more than one treatment is required

Side Effects of Carcinoid Tumor Treatment

Side effects depend on the treatment used and the patient's overall health. Not every patient experiences the same side effects, and many treatment-related problems can be managed with medical support.

After Surgery

Pain, tiredness, changes in bowel habits, reduced appetite, or wound-related problems may occur after surgery. Recovery depends on the type and extent of the operation.

Somatostatin Analog Medicines

Medicines such as octreotide or lanreotide may cause digestive symptoms, changes in blood sugar, or other medicine-specific effects. Doctors monitor patients according to the treatment being given.

PRRT Side Effects

PRRT can cause tiredness, nausea, temporary changes in blood counts, or other treatment-related effects. Kidney function and blood counts may be monitored during treatment.

Chemotherapy Side Effects

When chemotherapy is used, possible side effects can include fatigue, nausea, reduced blood counts, infection risk, appetite changes, hair loss, or other effects depending on the medicines used.

Radiation Side Effects

Radiation-related side effects depend on the body area being treated. The treating team explains the expected effects and how they can be managed.

Recovery & Follow-Up After Carcinoid Tumor Treatment

Follow-up is an important part of neuroendocrine tumor care. The schedule depends on the tumor location, grade, stage, treatment received, and risk of recurrence.

Scans

CT, MRI, PET imaging, or other scans may be used when clinically needed to check treatment response or look for recurrence. Not every patient needs every type of scan.

Blood and Urine Tests

Doctors may use blood or urine tests to monitor general health, organ function, or hormone-related markers when they are useful for that particular tumor.

Monitoring Hormone-Related Symptoms

Patients with hormone-producing tumors may need monitoring for symptoms such as flushing, diarrhea, wheezing, or changes in heart rate. Treatment may be adjusted if these symptoms change.

Nutrition

Maintaining good nutrition can help support recovery. Patients with diarrhea, poor appetite, weight loss, or other digestive problems may benefit from individualized nutrition advice.

Recurrence Monitoring

Follow-up appointments help doctors check for signs that the tumor has returned or changed. Patients should report new symptoms or unusual changes between scheduled visits.

When Should You See a Doctor?

Speak with a doctor if you have symptoms that are persistent, unexplained, or getting worse. Early medical assessment can help identify the cause and determine whether further testing is needed.

• Persistent abdominal pain or digestive problems
• Frequent or unexplained diarrhea
• Repeated flushing of the face or upper body
• Unexplained wheezing or breathing problems
• Unexplained weight loss
• Rectal bleeding
• A lump or abnormal finding on an imaging or endoscopy test
• Symptoms that return after previous carcinoid tumor treatment

Why Choose Fuda for Carcinoid Tumor Treatment?

Carcinoid tumors can require different types of treatment depending on the primary site, grade, stage, receptor status, and previous treatment. A personalized review can help determine which treatment options may be appropriate for an individual patient.

Carcinoid Tumor Treatment at Fuda Cancer Hospital

Patients can start by sharing their medical records for review. The available reports can help the medical team understand the diagnosis, tumor location, grade, stage, previous treatment, and current disease status before discussing possible treatment options.

Medical Report Review

Previous consultation notes, blood tests, scans, pathology reports, and treatment records can be reviewed as part of the initial case assessment.

Pathology Review

Pathology is important in neuroendocrine tumors because it can provide information about tumor type, differentiation, grade, and Ki-67. Reviewing the pathology report can help guide further treatment discussions.

Imaging Review

CT, MRI, PET, and somatostatin receptor imaging reports can be reviewed when available. Imaging helps doctors understand the location and extent of the disease.

Treatment Planning

The treatment plan is based on the complete medical picture. Depending on the case, doctors may discuss surgery, medicines, PRRT, radiation, chemotherapy, liver-directed treatment, or supportive care.

India Consultation and Coordination

Patients in India can use consultation and coordination services to discuss their diagnosis and available treatment options. An online consultation can also be considered when a patient is unable to visit immediately.

China Treatment Coordination, Where Applicable

In cases where treatment in China is considered, patients may receive assistance with the medical coordination process after their case has been reviewed. The need for treatment abroad, the recommended treatment, and its cost depend on the individual medical case and should be confirmed before making travel arrangements.